NexgenRX Inc. (NXG) - Total Liabilities

Latest as of September 2025: CA$30.91 Million CAD ≈ $22.36 Million USD

Based on the latest financial reports, NexgenRX Inc. (NXG) has total liabilities worth CA$30.91 Million CAD (≈ $22.36 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore NexgenRX Inc. (NXG) cash flow conversion to assess how effectively this company generates cash.

NexgenRX Inc. - Total Liabilities Trend (2013–2024)

This chart illustrates how NexgenRX Inc.'s total liabilities have evolved over time, based on quarterly financial data. See NexgenRX Inc. (NXG) net assets for net asset value and shareholders' equity analysis.

NexgenRX Inc. Competitors by Total Liabilities

The table below lists competitors of NexgenRX Inc. ranked by their total liabilities.

Company	Country	Total Liabilities
CNFinance Holdings Ltd NYSE:CNF	USA	$8.49 Billion
Epsium Enterprise Limited Ordinary Shares NASDAQ:EPSM	USA	$1.59 Million
Blender Financial Technologies Ltd TA:BLND	Israel	ILA135.04 Million
Genus PLC LSE:GNS	UK	GBX423.00 Million
Austin Gold Corp NYSE MKT:AUST	USA	$128.82K
Medifron DBT Co. Ltd KQ:065650	Korea	₩86.61 Billion
Ozaurum Resources Ltd AU:OZM	Australia	AU$443.16K
Cocrystal Pharma Inc NASDAQ:COCP	USA	$3.38 Million

Liability Composition Analysis (2013–2024)

This chart breaks down NexgenRX Inc.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see NXG stock market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.11	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	3.73	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.79	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how NexgenRX Inc.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for NexgenRX Inc. (2013–2024)

The table below shows the annual total liabilities of NexgenRX Inc. from 2013 to 2024.

Year	Total Liabilities	Change
2024-12-31	CA$22.84 Million ≈ $16.52 Million	+1.60%
2023-12-31	CA$22.48 Million ≈ $16.26 Million	+33.06%
2022-12-31	CA$16.90 Million ≈ $12.22 Million	-14.33%
2021-12-31	CA$19.72 Million ≈ $14.27 Million	0.00%
2020-12-31	CA$19.72 Million ≈ $14.27 Million	+1.91%
2019-12-31	CA$19.35 Million ≈ $14.00 Million	+20.46%
2018-12-31	CA$16.07 Million ≈ $11.62 Million	+108.48%
2017-12-31	CA$7.71 Million ≈ $5.57 Million	+3.75%
2016-12-31	CA$7.43 Million ≈ $5.37 Million	+11.78%
2015-12-31	CA$6.64 Million ≈ $4.81 Million	+462.28%
2014-12-31	CA$1.18 Million ≈ $854.86K	-13.94%
2013-12-31	CA$1.37 Million ≈ $993.35K	--

About NexgenRX Inc.

V:NXG Canada Health Information Services

Market Cap

$19.03 Million

CA$26.31 Million CAD

Market Cap Rank

#25175 Global

#994 in Canada

Share Price

CA$0.37

Change (1 day)

+2.78%

52-Week Range

CA$0.28 - CA$0.43

All Time High

CA$0.43